Live Breaking News & Updates on Precise Network Precision Interventions For Severe Asthma|Page 1

A new medication has been added to the treatment options for children with moderate-to-severe asthma. In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11. ....

Leonard Bacharier , Monroe Carell Jr , John Moore Lee , Janie Robinson , Emily Henderson , Centers For Disease , Pediatrics At Vanderbilt University School Of Medicine , Precise Network Precision Interventions For Severe Asthma , Liberty Asthma , New England Journal , Drug Administration , Monroe Carell , Disease Control , John Moore Lee Chair , Vanderbilt University School , Asthma Specialist , Precision Interventions , Severe Asthma , National Institutes , Clinical Trial ,